Outcome measures reported by cancer patients treated with tyrosine kinase inhibitors: a methodological study.
Ana Maria Teixeira Pires, Julie Ann Ponto, Eliana Cavalari Teraoka and 2 others
PMID 40172351WHAT IT FOUND
A shortened patient symptom checklist for oral cancer drugs called tyrosine kinase inhibitors was understood by the 18 patients who tried it and included symptoms experts judged relevant.
Key findings
01The final patient checklist had 20 questions.
02The initial item set reached 0.878 expert agreement, above the 0.80 target.
03None of the 18 patients in the pilot disagreed that they could understand the items and choose how they were feeling.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This was an instrument-building and pilot study, not a trial showing better patient outcomes. The pilot had only 18 patients, all from two São Paulo hospitals, and the patients had ECOG 0 or 1, so it does not show how the checklist works in more unwell or diverse patients. The expert panel was small: 15 were invited, 6 completed the first Delphi round and 3 completed the second. Some expert ratings for clarity were below the 0.80 target, with the overall clarity score 0.76. The checklist excludes adverse effects that need measurement or lab tests, such as weight loss, hypertension, liver or kidney changes, fever and myelotoxicity. New TKI medications may have symptoms not covered, so the list may need revision.
Declared interests
Funded by the Brazilian National Council for Scientific and Technological Development (CNPq).
The easy way to misread this
Do not read this as proof that the checklist improves cancer care. It was tested with 18 patients for understanding and with expert judges for relevance, and its clinical benefit still needs a separate study.